> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Baxter Recalls Novum IQ Infusion Pump
- URL: https://www.fdaweb.com/baxter-recalls-novum-iq-infusion-pump/
- Published: 2023-11-15T12:00:00.000Z
- Updated: 2026-09-14T14:16:15.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5155800

Baxter Healthcare has recalled (Class 1) its Novum IQ Syringe Infusion Pump because the device may indicate an infusion is complete when it is not. The problem has been identified as a software error that may “miscalculate volume after the pump detects a blockage (occlusion),” according to a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/baxter-healthcare-corporation-recalls-novum-iq-syringe-pump-potential-underdosing?utm%5Fmedium=email&utm%5Fsource=govdelivery).

The notice says that using the pump could lead to serious adverse health consequences and death. “People treated with the infusion pump might not get enough of the fluids they need, or time-sensitive treatment could be delayed,” it says. “Underdosing or delays could lead to serious adverse health consequences, especially for people receiving life-sustaining medications. In high-risk populations, insufficient fluid delivery could lead to death.”

The infusion pump is intended to help deliver fluids (nutrients or medications) into a patient’s body in a controlled manner, the notice says. The device is used in hospitals and outpatient healthcare facilities in adults, pediatrics, and neonates.